Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14851 - 14875 of 14959 in total
5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. Known drug targets of 5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole include genome polyprotein.
Experimental
Etofibrate is a fibrate produced by the combination of clofibrate ester linked to niacin. These components separate in the body slowly allowing for pharmacokinetics similar to controlled-release formulations.
Experimental
UK-390,957 has been used in trials studying the treatment of Ejaculation.
Investigational
Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
Investigational
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Nelotanserin has been used in trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and REM Sleep Behavior Disorder. It is a highly selective antagonist at the 5-HT2A serotonin receptor. It increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM...
Investigational
Matched Description: … trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and
Displaying drugs 14851 - 14875 of 14959 in total